These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34538526)

  • 21. Improving immunization data quality in Peru and Mexico: Two case studies highlighting challenges and lessons learned.
    Trumbo SP; Contreras M; García AGF; Díaz FAE; Gómez M; Carrión V; Ruiz KJP; Aquije R; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2018 Nov; 36(50):7674-7681. PubMed ID: 30414780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
    Utazi CE; Wagai J; Pannell O; Cutts FT; Rhoda DA; Ferrari MJ; Dieng B; Oteri J; Danovaro-Holliday MC; Adeniran A; Tatem AJ
    Vaccine; 2020 Mar; 38(14):3062-3071. PubMed ID: 32122718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving polio vaccination coverage in Nigeria through the use of geographic information system technology.
    Barau I; Zubairu M; Mwanza MN; Seaman VY
    J Infect Dis; 2014 Nov; 210 Suppl 1():S102-10. PubMed ID: 25316823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.
    Gallagher KE; Erio T; Baisley K; Lees S; Watson-Jones D
    BMC Health Serv Res; 2018 Mar; 18(1):173. PubMed ID: 29530042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobile Money and the importance of timely, complete payments to frontline health campaign workers in the fight to eradicate polio: pilot experience from a World Health Organization digital payment platform in Africa.
    Hamani A; Hussein Jama I; Roland MAY; Wanjeri L; Oppon-Kusi AA; Karimi D; Kiconco P; Akpotu OE; Saka M
    BMC Health Serv Res; 2023 Jan; 23(1):16. PubMed ID: 36611190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?
    Waheed DE; Bolio A; Guillaume D; Sidibe A; Morgan C; Karafillakis E; Holloway M; Van Damme P; Limaye R; Vorsters A
    Front Public Health; 2023; 11():1112981. PubMed ID: 37124764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
    Elias Chitio JJ; Baltazar CS; Langa JP; Baloi LD; Mboane RBJ; Manuel JA; Assane S; Omar A; Manso M; Capitine I; Van Rensburg C; Luiz N; Mogasale V; Marks F; Park SE; Beck NS
    BMJ Open; 2022 Sep; 12(9):e053585. PubMed ID: 36547726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
    Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
    Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect.
    Schumacher S; Salmanton-García J; Cornely OA; Mellinghoff SC
    Infection; 2021 Jun; 49(3):387-399. PubMed ID: 33284427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru.
    Augustovski F; Bardach A; Santoro A; Rodriguez-Cairoli F; López-Osornio A; Argento F; Havela M; Blumenfeld A; Ballivian J; Solioz G; Capula A; López A; Cejas C; Savedoff W; Palacios A; Rubinstein A; Pichon-Riviere A
    Cost Eff Resour Alloc; 2023 Apr; 21(1):21. PubMed ID: 37005606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.
    Ladner J; Besson MH; Audureau E; Rodrigues M; Saba J
    BMC Health Serv Res; 2016 Oct; 16(1):575. PubMed ID: 27737666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
    Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
    Elife; 2021 Jun; 10():. PubMed ID: 34165077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A scoping review on integrated health campaigns for immunization in low- and middle-income countries.
    Ahmed ST; Haider SS; Hanif S; Anwar HB; Mehjabeen S; Closser S; Bazant E; Sarker M
    Health Policy Plan; 2023 Nov; 38(10):1198-1224. PubMed ID: 37699072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV immunization in Brazil and proposals to increase adherence to vaccination campaigns.
    Santos WM; Santos DM; Fernandes MS
    Rev Saude Publica; 2023; 57():79. PubMed ID: 37937653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of mass campaigns in the expanded program on immunization: a review of reported advantages and disadvantages.
    Dietz V; Cutts F
    Int J Health Serv; 1997; 27(4):767-90. PubMed ID: 9399118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.